Total bilirubin < . times upper limit of normal except for known conjugation diseases such as Gilberts; direct bilirubin is not an inclusion criteria
TREATMENT WITH SJCAR: Total bilirubin =<  times the upper limit of normal for age, except in subjects with Gilberts syndrome
Serum bilirubin >= . x upper limit of normal (ULN), patients with Gilberts syndrome and a total bilirubin of <  times ULN are permitted)
Total bilirubin >  times the upper limit of normal OR in patients with Gilberts syndrome, a total bilirubin > .
Serum bilirubin > . times the upper limit of normal (ULN) (except patients with Gilberts syndrome: total bilirubin of >  x ULN) at the time of screening
Total bilirubin =< . times upper limit of normal (x ULN) (=<  x ULN if considered to be due to leukemic involvement or Gilberts syndrome)
Total bilirubin =<  times the upper limit of normal (ULN) (or =< . x ULN if deemed to be elevated due to Gilberts disease or leukemia)
Total bilirubin of =< . times upper limit of normal (exception is made for patients with Gilberts syndrome who may be considered eligible if total bilirubin is <  times upper limit of normal)
Total bilirubin =<  times upper limit of normal (x ULN) ( x ULN if considered to be due to leukemia involvement or Gilberts syndrome)
Total bilirubin =<  times upper limit of normal (x ULN) (=<  x ULN if considered to be due to leukemic involvement or Gilberts syndrome)
Total bilirubin <  times upper limit of normal (unless due to Gilberts syndrome), performed within  days prior to registration
Serum bilirubin < . times the upper limit of normal (ULN); unless due to Gilberts syndrome (in which <  times ULN acceptable)
Total bilirubin =<  times the upper limit of normal (ULN) (except patients with Gilberts syndrome who must have a total bilirubin of <  times ULN)
Bilirubin =< . times (x) upper limit of normal (ULN) (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
Total bilirubin <  times the upper limit of normal (ULN) (except patients with Gilberts syndrome who must have a total bilirubin of <  times ULN)
Total bilirubin < . times the institutional upper limit of normal (ULN); subjects with Gilberts syndrome and total bilirubin >= . times the upper limit of normal are eligible to participate
Total bilirubin =<  times upper limit of normal (x ULN) (=<  x ULN if considered to be due to leukemic involvement or Gilberts syndrome)
Total bilirubin =< . times the upper limit of normal (ULN) unless due to Gilberts disease or hemolysis, then =< . times ULN
Total bilirubin <  times the upper limit of normal (ULN) (except patients with Gilberts syndrome who must have a total bilirubin of <  times ULN)
Bilirubin <  times the upper limit of normal (ULN) (except patients with Gilberts syndrome who must have a total bilirubin of <  times ULN)
Total bilirubin =< . times upper limit of normal unless due to Gilberts disease within  days before enrollment
Bilirubin <  times the upper limit of normal (ULN) (except patients with Gilberts syndrome who must have a total bilirubin of <  times ULN)
Serum bilirubin =< . times the upper institutional limits of normal (ULN); patients with a history of Gilberts syndrome may be enrolled if the total bilirubin is <  mg/dL with a predominance of indirect bilirubin
Total bilirubin =< . times the upper limit of normal (ULN); for patients with known Gilberts disease, total bilirubin should be =<  mg/dL
Adequate liver function, as evidenced by total serum bilirubin =< . times the upper limit of normal (patients with Gilberts disease are eligible, provided intermittent indirect hyperbilirubinemia)
Within  weeks of randomization: Serum bilirubin =< . times the upper institutional limits of normal (ULN); patients with a history of Gilberts syndrome may be enrolled if the total bilirubin is <  mg/dL with a predominance of indirect bilirubin
Total bilirubin =<  times upper limit of normal (x ULN) (=<  x ULN if considered to be due to leukemic involvement or Gilberts syndrome)
Total bilirubin >  times upper normal limit (unless due to tumor involvement of liver or a known history of Gilberts disease)
Total bilirubin =< . times the upper normal limit (UNL), except patients with Gilberts syndrome in whom total bilirubin must be < . mg/dL
Total bilirubin <  times the upper limit of normal (ULN) (except patients with Gilberts syndrome who must have a total bilirubin of <  times ULN)
Total bilirubin less than . times upper limit of normal (ULN), or less than  times ULN at study entry in a patient with documented Gilberts disease
Total bilirubin <  times the upper limit of normal (ULN) (except patients with Gilberts syndrome who must have a total bilirubin of <  times ULN)
Bilirubin (total) =< . times upper limit normal (with exception of Gilberts syndrome)